vimarsana.com

Latest Breaking News On - Bipolari disorder who are early - Page 1 : vimarsana.com

Alkermes plc: Alkermes Showcases Research from Psychiatry Portfolio at Psych Congress

? Clinical, Epidemiology and Health Economics and Outcomes Research Shared at Key Psychiatry Conference ? DUBLIN, Sept. 20, 2022 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced

United statesCraig hopkinsonMarisa borgasanoAripiprazole lauroxilSandy coombsPsych congressWellness survey dataResearch development at alkermesAnalysis of national healthOutcomes research shared at key psychiatry conferenceHealth economicsAlkermes incAlkermes pharma irelandOutcomes research sharedKey psychiatry conferenceChief medical officer

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International.

New yorkUnited statesAlex braunCraig hopkinsonMarisa borgasanoAripiprazole lauroxilBehavioral health systemResearch databasesSchizophrenia international research societyResearch development at alkermesDepartment of psychiatryIcahn school of medicine at mount sinaiAlkermes incAlkermes pharma irelandDetailed results presented fromEarly phase

Alkermes plc: Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today presented

New yorkUnited statesAlex braunCraig hopkinsonMarisa borgasanoAripiprazole lauroxilBehavioral health systemResearch databasesSchizophrenia international research societyResearch development at alkermesDepartment of psychiatryIcahn school of medicine at mount sinaiAlkermes incAlkermes pharma irelandResults presented fromEarly phase

vimarsana © 2020. All Rights Reserved.